BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 19384176)

  • 1. Rituximab for humoral rejection after kidney transplantation: an update.
    Rostaing L; Guilbeau-Frugier C; Kamar N
    Transplantation; 2009 Apr; 87(8):1261. PubMed ID: 19384176
    [No Abstract]   [Full Text] [Related]  

  • 2. Single dose of Rituximab plus plasmapheresis in an HIV patient with acute humoral kidney transplant rejection: a case report.
    Moscoso-Solorzano GT; Baltar JM; Seco M; López-Larrea C; Mastroianni-Kirsztajn G; Ortega F
    Transplant Proc; 2007 Dec; 39(10):3460-2. PubMed ID: 18089407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab and intravenous immunoglobulin treatment of chronic antibody-mediated kidney allograft rejection.
    Fehr T; Rüsi B; Fischer A; Hopfer H; Wüthrich RP; Gaspert A
    Transplantation; 2009 Jun; 87(12):1837-41. PubMed ID: 19543061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-mediated rejection: treatment alternatives and outcomes.
    Singh N; Pirsch J; Samaniego M
    Transplant Rev (Orlando); 2009 Jan; 23(1):34-46. PubMed ID: 19027615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful therapy with rituximab of refractory acute humoral renal transplant rejection: a case report.
    Celik A; Saglam F; Cavdar C; Sifil A; Atila K; Sarioglu S; Bora S; Gulay H; Camsari T
    Transplant Proc; 2008; 40(1):302-4. PubMed ID: 18261611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of acute humoral rejection in kidney transplantation with plasmapheresis.
    Grandtnerová B; Javorský P; Kolácný J; Hovoricová B; Dĕdic P; Laca L
    Transplant Proc; 1995 Feb; 27(1):934-5. PubMed ID: 7879238
    [No Abstract]   [Full Text] [Related]  

  • 7. ABO blood type incompatible kidney transplantation without splenectomy prepared with plasma exchange and rituximab.
    Chikaraishi T; Sasaki H; Tsutsumi H; Miyano S; Nakazawa R; Nakano T; Kitajima K; Kudo H; Takahashi T; Sato Y; Kimura K
    Transplant Proc; 2008 Dec; 40(10):3445-7. PubMed ID: 19100409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-dose rituximab as induction in renal transplantation.
    van den Hoogen MW; Hilbrands LB
    Transplantation; 2010 May; 89(10):1295; author reply 1295. PubMed ID: 20555227
    [No Abstract]   [Full Text] [Related]  

  • 9. B cell survival in intragraft tertiary lymphoid organs after rituximab therapy.
    Thaunat O; Patey N; Gautreau C; Lechaton S; Fremeaux-Bacchi V; Dieu-Nosjean MC; Cassuto-Viguier E; Legendre C; Delahousse M; Lang P; Michel JB; Nicoletti A
    Transplantation; 2008 Jun; 85(11):1648-53. PubMed ID: 18551073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current approaches to treatment of antibody-mediated rejection.
    Jordan SC; Vo AA; Tyan D; Nast CC; Toyoda M
    Pediatr Transplant; 2005 Jun; 9(3):408-15. PubMed ID: 15910400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New treatments for acute humoral rejection of kidney allografts.
    Venetz JP; Pascual M
    Expert Opin Investig Drugs; 2007 May; 16(5):625-33. PubMed ID: 17461736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapy with plasmapheresis and intravenous immunoglobulin for acute humoral rejection in kidney transplantation.
    Ibernón M; Gil-Vernet S; Carrera M; Serón D; Moreso F; Bestard O; Cruzado JM; Grinyó JM
    Transplant Proc; 2005 Nov; 37(9):3743-5. PubMed ID: 16386524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Humoral antibody-mediated rejection in kidney transplants].
    Teraoka S; Kai K
    Nihon Jinzo Gakkai Shi; 2005; 47(5):497-507. PubMed ID: 16130404
    [No Abstract]   [Full Text] [Related]  

  • 14. An interesting case.
    Ramírez-González J; Pérez-Garrido J; Rodríguez-Romo R; Uribe-Uribe N; de Leo C; Morales-Buenrostro LE; Alberú J
    Clin Transpl; 2006; ():566-9. PubMed ID: 18365437
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug insight: rituximab in renal disease and transplantation.
    Salama AD; Pusey CD
    Nat Clin Pract Nephrol; 2006 Apr; 2(4):221-30. PubMed ID: 16932428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BAFF may modulate the rate of B-cell repopulation after rituximab therapy for acute renal transplant rejection.
    Zarkhin V; Li L; Sarwal MM
    Transplantation; 2009 Nov; 88(10):1229-30. PubMed ID: 19935379
    [No Abstract]   [Full Text] [Related]  

  • 17. Is a single low-fixed dose of rituximab sufficient for treating acute humoral rejection after kidney transplantation?
    Kamar N; Rostaing L
    Transplantation; 2009 Jul; 88(1):142; author reply 142-3. PubMed ID: 19584695
    [No Abstract]   [Full Text] [Related]  

  • 18. Transplantation across previously incompatible immunological barriers.
    Magee CC
    Transpl Int; 2006 Feb; 19(2):87-97. PubMed ID: 16441356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basic mechanisms of humoral rejection.
    Cascalho M; Platt JL
    Pediatr Transplant; 2005 Feb; 9(1):9-16. PubMed ID: 15667605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single low-fixed dose of rituximab to salvage renal transplants from refractory antibody-mediated rejection.
    Mulley WR; Hudson FJ; Tait BD; Skene AM; Dowling JP; Kerr PG; Kanellis J
    Transplantation; 2009 Jan; 87(2):286-9. PubMed ID: 19155986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.